tiprankstipranks
TriSalus Life Sciences (TLSI)
NASDAQ:TLSI
US Market
TLSI
TriSalus Life Sciences
RESEARCH TOOLSreports
Want to see TLSI full AI Analyst Report?

TriSalus Life Sciences (TLSI) Stock Forecast & Price Target

81 Followers
See the Price Targets and Ratings of:

TLSI Analyst Ratings

Strong Buy
5Ratings
Strong Buy
5 Buy
0 Hold
0 Sell
Based on 5 analysts giving stock ratings to
TriSalus
Life Sciences
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

TLSI Stock 12 Month Forecast

Average Price Target

$8.80
▲(89.25% Upside)
Based on 5 Wall Street analysts offering 12 month price targets for TriSalus Life Sciences in the last 3 months. The average price target is $8.80 with a high forecast of $11.00 and a low forecast of $7.00. The average price target represents a 89.25% change from the last price of $4.65.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"3":"$3","12":"$12","5.25":"$5.25","7.5":"$7.5","9.75":"$9.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":11,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$11.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8.8,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$8.80</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$7.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[3,5.25,7.5,9.75,12],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.39,4.898461538461538,5.406923076923077,5.915384615384616,6.423846153846154,6.932307692307692,7.440769230769231,7.94923076923077,8.457692307692309,8.966153846153848,9.474615384615385,9.983076923076922,10.491538461538461,{"y":11,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.39,4.729230769230769,5.068461538461539,5.407692307692308,5.746923076923077,6.086153846153847,6.4253846153846155,6.764615384615385,7.103846153846154,7.443076923076924,7.782307692307693,8.121538461538462,8.46076923076923,{"y":8.8,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.39,4.59076923076923,4.791538461538461,4.992307692307692,5.193076923076923,5.3938461538461535,5.594615384615384,5.795384615384615,5.996153846153846,6.196923076923077,6.397692307692307,6.598461538461539,6.799230769230769,{"y":7,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5.09,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.21,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.15,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.18,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.16,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.56,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.74,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.98,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.11,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.01,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.18,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.39,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$11.00Average Price Target$8.80Lowest Price Target$7.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Lake Street Analyst forecast on TLSI
Frank Takkinen
Lake Street
Lake Street
$8
Buy
72.04%
Upside
Reiterated
05/29/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Maxim Group Analyst forecast on TLSI
Jason McCarthy
Maxim Group
Maxim Group
$10
Buy
115.05%
Upside
Reiterated
05/14/26
Maxim Group Reaffirms Their Buy Rating on TriSalus Life Sciences (TLSI)
JonesTrading Analyst forecast on TLSI
Justin Walsh
JonesTrading
JonesTrading
$11
Buy
136.56%
Upside
Reiterated
05/13/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Intellia Therapeutics (NASDAQ: NTLA), TriSalus Life Sciences (NASDAQ: TLSI) and Fractyl Health, Inc. (NASDAQ: GUTS)
Canaccord Genuity Analyst forecast on TLSI
William Plovanic
Canaccord Genuity
Canaccord Genuity
$7
Buy
50.54%
Upside
Reiterated
05/13/26
Canaccord Genuity Reaffirms Their Buy Rating on TriSalus Life Sciences (TLSI)
Northland Securities Analyst forecast on TLSI
Carl Byrnes
Northland Securities
Northland Securities
$12.5→$8
Buy
72.04%
Upside
Assigned
03/23/26
TriSalus Life Sciences price target lowered to $8 from $12.50 at NorthlandTriSalus Life Sciences price target lowered to $8 from $12.50 at Northland
Oppenheimer Analyst forecast on TLSI
Suraj Kalia
Oppenheimer
Oppenheimer
$10
Buy
115.05%
Upside
Reiterated
11/14/25
Oppenheimer Remains a Buy on TriSalus Life Sciences (TLSI)
Cantor Fitzgerald Analyst forecast on TLSI
Ross Osborn
Cantor Fitzgerald
Cantor Fitzgerald
$9
Buy
93.55%
Upside
Reiterated
06/09/25
TriSalus Life Sciences (TLSI) Receives a Buy from Cantor Fitzgerald
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Lake Street Analyst forecast on TLSI
Frank Takkinen
Lake Street
Lake Street
$8
Buy
72.04%
Upside
Reiterated
05/29/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Maxim Group Analyst forecast on TLSI
Jason McCarthy
Maxim Group
Maxim Group
$10
Buy
115.05%
Upside
Reiterated
05/14/26
Maxim Group Reaffirms Their Buy Rating on TriSalus Life Sciences (TLSI)
JonesTrading Analyst forecast on TLSI
Justin Walsh
JonesTrading
JonesTrading
$11
Buy
136.56%
Upside
Reiterated
05/13/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Intellia Therapeutics (NASDAQ: NTLA), TriSalus Life Sciences (NASDAQ: TLSI) and Fractyl Health, Inc. (NASDAQ: GUTS)
Canaccord Genuity Analyst forecast on TLSI
William Plovanic
Canaccord Genuity
Canaccord Genuity
$7
Buy
50.54%
Upside
Reiterated
05/13/26
Canaccord Genuity Reaffirms Their Buy Rating on TriSalus Life Sciences (TLSI)
Northland Securities Analyst forecast on TLSI
Carl Byrnes
Northland Securities
Northland Securities
$12.5→$8
Buy
72.04%
Upside
Assigned
03/23/26
TriSalus Life Sciences price target lowered to $8 from $12.50 at NorthlandTriSalus Life Sciences price target lowered to $8 from $12.50 at Northland
Oppenheimer Analyst forecast on TLSI
Suraj Kalia
Oppenheimer
Oppenheimer
$10
Buy
115.05%
Upside
Reiterated
11/14/25
Oppenheimer Remains a Buy on TriSalus Life Sciences (TLSI)
Cantor Fitzgerald Analyst forecast on TLSI
Ross Osborn
Cantor Fitzgerald
Cantor Fitzgerald
$9
Buy
93.55%
Upside
Reiterated
06/09/25
TriSalus Life Sciences (TLSI) Receives a Buy from Cantor Fitzgerald
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering TriSalus Life Sciences

3 Months
Justin WalshJonesTrading
Success Rate
5/13 ratings generated profit
38%
Average Return
-9.53%
Copying Justin Walsh's trades and holding each position for 3 Months would result in 38.46% of your transactions generating a profit, with an average return of -9.53% per trade.
1 Year
Justin WalshJonesTrading
Success Rate
3/13 ratings generated profit
23%
Average Return
-20.04%
Copying Justin Walsh's trades and holding each position for 1 Year would result in 23.08% of your transactions generating a profit, with an average return of -20.04% per trade.
2 Years
Justin WalshJonesTrading
Success Rate
1/13 ratings generated profit
8%
Average Return
-31.42%
Copying Justin Walsh's trades and holding each position for 2 Years would result in 7.69% of your transactions generating a profit, with an average return of -31.42% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

TLSI Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
14
7
12
8
14
Buy
2
2
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
16
9
12
8
14
In the current month, TLSI has received 14 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. TLSI average Analyst price target in the past 3 months is 8.80.
Each month's total comprises the sum of three months' worth of ratings.

TLSI Financial Forecast

TLSI Earnings Forecast

Next quarter’s earnings estimate for TLSI is -$0.15 with a range of -$0.19 to -$0.11. The previous quarter’s EPS was $0.03. TLSI beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year TLSI has Performed in-line its overall industry.
Next quarter’s earnings estimate for TLSI is -$0.15 with a range of -$0.19 to -$0.11. The previous quarter’s EPS was $0.03. TLSI beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year TLSI has Performed in-line its overall industry.

TLSI Sales Forecast

Next quarter’s sales forecast for TLSI is $10.79M with a range of $10.00M to $12.90M. The previous quarter’s sales results were $8.90M. TLSI beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year TLSI has Performed in-line its overall industry.
Next quarter’s sales forecast for TLSI is $10.79M with a range of $10.00M to $12.90M. The previous quarter’s sales results were $8.90M. TLSI beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year TLSI has Performed in-line its overall industry.

TLSI Stock Forecast FAQ

What is TLSI’s average 12-month price target, according to analysts?
Based on analyst ratings, TriSalus Life Sciences’s 12-month average price target is 8.80.
    What is TLSI’s upside potential, based on the analysts’ average price target?
    TriSalus Life Sciences has 89.25% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is TLSI a Buy, Sell or Hold?
          TriSalus Life Sciences has a consensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
            What is TriSalus Life Sciences’s price target?
            The average price target for TriSalus Life Sciences is 8.80. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $11.00 ,the lowest forecast is $7.00. The average price target represents 89.25% Increase from the current price of $4.65.
              What do analysts say about TriSalus Life Sciences?
              TriSalus Life Sciences’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
                How can I buy shares of TLSI?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.